Ways Your Patients Can Save on Jardiance

Many patients living with Type 2 diabetes, chronic kidney disease, or heart failure rely on Jardiance (empagliflozin). But it can come at an expense.

The average retail price of Jardiance is over $500 for a 30-day supply. In many cases, it’s covered by insurance. According to the manufacturer, most people with commercial insurance or Medicare Part D pay between $0 and $50 per month for their prescription. People who have Medicaid pay between $0 and $10.

Coverage, though, isn’t always reliable, and the first Jardiance generic may not be available until 2029 at the earliest. So let’s review some other options and ways to save.

GoodRx coupon

A GoodRx coupon could help patients save on Jardiance without insurance. Anyone with a valid prescription, regardless of insurance status, can use GoodRx to purchase Jardiance at an exclusive cash price.

Here’s how patients can get a coupon:

1. Go to www.goodrx.com or open the GoodRx mobile app.

2. Type “Jardiance” in the search bar.

3. Click “Start saving,” or tap or click return.

4. Select the correct dose and quantity, along with the location.

5. Choose to get the coupon by text or email, or print it out.

If possible, tell your patient to show the coupon at the pharmacy before the staff start filling the prescription to avoid delays in processing. You can also send the coupon information to the pharmacy at the same time as you send in your patient’s prescription.

Keep in mind: GoodRx savings may vary by pharmacy and location. The GoodRx website and app can help users compare prices locally.

Copay card

The manufacturer of Jardiance, Boehringer Ingelheim, offers a copay savings card that can reduce the copay to as little as $0 per prescription.

Patient assistance programs

The Boehringer Ingelheim Cares Foundation Patient Assistance Program is another good option for those who qualify.

Alternative medications

Jardiance is one of several medications in the class of sodium-glucose cotransporter-2 (SGLT2) inhibitors. Here’s a quick look at a few other options:

For patients with Type 2 diabetes, heart failure, and/or chronic kidney disease (CKD):

• Farxiga (dapagliflozin) is another SGLT2 inhibitor with a generic version available. According to ADA guidelines, either can be prescribed for Type 2 diabetes patients at high cardiovascular or heart-failure risk, but there are differences in the precise wording of the heart failure and cardiovascular indications and in the renal cutoffs for glycemic use.

For your patients:

Comparison of Farxiga versus Jardiance

For patients with Type 2 diabetes and heart disease:

• Invokana (canagliflozin) does not have a generic version. It also lacks a non-diabetic heart failure or CKD indication.

For patients with Type 2 diabetes only:

• Brenzavvy (bexagliflozin)

• Steglatro (ertugliflozin)

For patients at risk of serious cardiovascular events due to heart failure or other related risk factors, such as Type 2 diabetes or CKD:

• Inpefa (sotagliflozin)

Why trust our experts?

Written by:

Alyssa Billingsley, PharmD

Alyssa Billingsley, PharmD, is the director of pharmacy content for GoodRx. She has over a decade of experience as a pharmacist and has worked in clinical, academic, and administrative roles.

Edited by:

Mandy Armitage, MD

Mandy Armitage, MD, has combined clinical medicine with her passion for education and content development for many years. She is co-executive director at Nonclinical Physicians Network and has served as medical director for the health technology companies HealthLoop (now Get Well) and Doximity.

Reviewed by:

Christina Aungst, PharmD, MWC

Christina Aungst, PharmD, MWC is a senior pharmacy editor for GoodRx. She began writing for GoodRx Health in 2019.

Our editorial standards

Meet our experts